Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/20—Protective coatings for natural or artificial teeth, e.g. sealings, dye coatings or varnish
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/30—Compositions for temporarily or permanently fixing teeth or palates, e.g. primers for dental adhesives
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
  • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
  • A61K6/887—Compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K6/00—Preparations for dentistry
  • A61K6/80—Preparations for artificial teeth, for filling teeth or for capping teeth
  • A61K6/884—Preparations for artificial teeth, for filling teeth or for capping teeth comprising natural or synthetic resins
  • A61K6/891—Compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
  • A61K6/893—Polyurethanes

Definitions

• the present invention is directed toward compositions containing polymerizable bisphosphonic acids that can be used in a variety of applications, particularly medical, dental, and orthodontic applications, for example.
• Such compositions are particularly useful as etchants, especially self-etching primers and self-etching adhesives, to promote adhesion of dental restoratives, orthodontic appliances, etc., to dental structures.
• the restoration of decayed dental structures including caries, decayed dentin or decayed enamel is often accomplished by the sequential application of a dental adhesive and then a dental material (e.g., a restorative material) to the relevant dental structures.
• a dental material e.g., a restorative material
• adhesives are used in the bonding of orthodontic appliances (generally also utilizing an orthodontic adhesive) to a dental structure.
• various pretreatment processes are used to promote the bonding of adhesives to dentin or enamel, for example.
• pretreatment steps include etching using, for example, inorganic or organic acids, followed by priming to improve the bonding between the tooth structure and the overlying adhesive.
• etchants, primers, and adhesives are typically applied in a step-wise fashion. Often between such steps, one or more rinsing and drying steps are used. As a result, dental restoration and the application of orthodontic appliances typically involve multi-step procedures.
• a self-etching primer particularly a self-etching dental primer, for improved bonding of an adhesive (e.g., a dental adhesive) to a substrate surface (e.g., dental structure, such as dentin, enamel, bone, or other hard tissue) and that could eliminate the conventional post-etching rinsing and drying steps.
• an adhesive e.g., a dental adhesive
• a substrate surface e.g., dental structure, such as dentin, enamel, bone, or other hard tissue
• new compositions that can serve as self-etching adhesives, i.e., a single-composition adhesive with priming and etching properties that can be applied in a single pretreatment step. Preferred embodiments of the present invention meet some of these needs.
• compositions containing one or more polymerizable bisphosphonic acids, salts thereof, or combinations thereof are useful in a variety of medical and dental applications, for example, as etchants, particularly self-etching primers (i.e., etchant/primer compositions).
• etchants particularly self-etching primers (i.e., etchant/primer compositions).
• etchant/primer compositions can be used in methods and kits for improving the bonding of adhesives (and subsequently the adherence of a material, e.g., a dental restorative or an orthodontic appliance) to a hard surface, preferably, to at least one type of medical structure or dental structure.
• compositions of the present invention also function as self-etching adhesives (i.e., etchant/primer/adhesive compositions).
• compositions of the present invention include one or more polymerizable bisphosphonic acids of Formula I, or more particularly, one or more polymerizable bisphosphonic acids of Formula II.
• Such compounds can be in their acid form (as shown) or in their salt form.
• R 1 is an organic group that includes a polymerizable group
• R 2 is H, OR, SR, N(R) 2 , or an organic group that can optionally join with R 1 to form a carbon-carbon double bond with the carbon between the two phosphorus atoms (i.e., the R 1 and R 2 groups are one and the same with a C ⁇ C bond), wherein the organic group optionally includes a polymerizable group, and further wherein each R is independently hydrogen or an organic group optionally including a polymerizable group.
• the R groups may be the same or different.
• R 2 is H, OH, an alkyl group, an aryl group, an alkoxy group, an aryloxy group, or -A-(N(R 4 )—C(O)—C(R 3 ) ⁇ CH 2 ) x ; each R 3 is independently H or CH 3 ; each R 4 is H, an alkyl group, or can be joined to A forming a cyclic organic group; and A is a bond or a straight chain or branched organic group.
• the groups -A-(N(R 4 )—C(O)—C(R 3 ) ⁇ CH 2 ) x may be the same or different.
• the polymerizable bisphosphonic acid is present in an amount of at least about 1 percent by weight (wt-%), more preferably, at least about 5 wt-%, based on the total weight of the composition.
• a of Formula II is a straight chain or branched organic group when the composition includes a polymerizable component that is different from the compound of Formula II and is otherwise formulated for use as an etchant, more preferably a self-etching primer or a self-etching adhesive, which is particularly useful on hard tissue.
• a of Formula II is a bond or a straight chain or branched organic group when the composition includes a polymerizable component that is different from the compound of Formula II and the compound of Formula II is present in an amount of at least about 1 wt-%, based on the total weight of the composition.
• compositions of the present invention are self-etching primers, thereby being capable of etching and priming a hard surface, particularly a tooth surface, simultaneously.
• a separate dental primer can be used if desired.
• compositions of the present invention are self-etching adhesives, which can, for example, promote adherence of a dental material (e.g., a composite, a filling, a sealant, an inlay, an onlay, a crown, and a bridge) to the tooth surface.
• a dental material e.g., a composite, a filling, a sealant, an inlay, an onlay, a crown, and a bridge
• a separate dental adhesive can be used if desired.
• Certain methods of the present invention involve treating a hard surface that includes etching the hard surface with a composition of the present invention with the proviso that the hard surface is not pretreated.
• compositions of the present invention can function to promote the adherence of an orthodontic adhesive to the tooth surface, wherein the orthodontic adhesive functions to adhere an orthodontic appliance to the tooth surface.
• an orthodontic appliance e.g., a bracket, a buccal tube, a band, a cleat, a button, a lingual retainer, and a bite blocker
• a composition including a polymerizable bisphosphonic acid e.g., a bracket, a buccal tube, a band, a cleat, a button, a lingual retainer, and a bite blocker
• an orthodontic adhesive is adhered to the tooth surface, which can optionally be pre-applied to the orthodontic appliance before adhering to the tooth surface.
• the method can also optionally include a step of priming the tooth surface prior to adhering an orthodontic appliance to the tooth surface. If the composition further includes at least one polymerizable component different from the polymerizable bisphosphonic acid, the steps of etching and priming are done simultaneously with the composition functioning as a self-etching primer composition.
• the method can also optionally include a step of applying a dental adhesive to the tooth surface prior to adhering an orthodontic appliance to the tooth surface.
• the steps of etching and applying a dental adhesive are done simultaneously with the composition acting as a self-etching adhesive composition.
• the methods of the present invention can include adhering an orthodontic adhesive to the tooth surface, wherein preferably the orthodontic adhesive has been pre-applied to the orthodontic appliance before adhering to the tooth surface.
• “adhesive” or “dental adhesive” refers to a composition used as a pre-treatment on a dental structure (e.g., a tooth) to adhere a “dental material” (e.g., “restorative”), an orthodontic appliance (e.g., bracket), or an “orthodontic adhesive” to the dental structure.
• An “orthodontic adhesive” refers to a highly (generally greater than 40% by weight) filled composition (more analogous to a “restorative material” than to a “dental adhesive”) used to adhere an orthodontic appliance to a dental structure (e.g., tooth) surface.
• the tooth surface is pre-treated, e.g., by etching, priming, and/or applying an adhesive to enhance the adhesion of the “orthodontic adhesive” to the tooth surface.
• “Dental structures” refer to tooth structures (e.g., enamel and dentin) and bone, for example.
• the present invention is directed to compositions containing one or more polymerizable bisphosphonic acids.
• this includes the acid form, salts thereof, or combinations thereof.
• the compositions also include one or more additional polymerizable components.
• compositions of the present invention are useful for treating hard surfaces, preferably, hard tissues such as dentin, enamel, and bone.
• hard tissues such as dentin, enamel, and bone.
• the compositions of the present invention are particularly desirable for use on at least one type of medical structure (e.g., bone, cartilage, medical instruments) or dental structure (e.g., dentin, enamel, or bone), they can be used to etch, preferably etch and prime, hard surfaces such as metal and metal oxide surfaces.
• the compositions of the present invention are typically used with an overlying adhesive (e.g., a dental adhesive), but they can be used as the adhesive (i.e., a self-etching adhesive) in certain preferred embodiments.
• compositions of the present invention are useful as etchants for hard surfaces.
• the compositions are self-etching primers. That is, they can etch and prime a surface in one step, thereby eliminating conventional post-etching rinsing and drying steps. An adhesive is then applied over the etched and primed surface.
• the compositions are self-etching adhesives. That is, they etch and prime a surface in one step and function as an adhesive.
• Such self-etching primer and self-etching adhesive compositions are typically prepared by the addition of one or more polymerizable components to a bisphosphonic acid compound.
• the selection of additional polymerizable components is made to impart the desired priming and/or adhesive properties to the compositions.
• techniques for selecting polymerizable components and optional other components to impart priming and/or adhesive properties to hard-surface treatment compositions are well known to those skilled in formulation of dental and medical materials.
• Suitable polymerizable components for use in such compositions, as well as conventional dental primers and dental adhesives that can be incorporated into the compositions, or used separately but in combination with the compositions, are discussed herein.
• priming and/or adhesive properties may be imparted to the composition by chemical modification of the bisphosphonic acid(s) without the addition of other polymerizable components to the composition.
• compositions of the present invention are preferably used to promote the adhesion of a material (e.g., a dental restorative or orthodontic appliance) to a hard surface, particularly a tooth surface (e.g., enamel or dentin).
• a material e.g., a dental restorative or orthodontic appliance
• the compositions are hardened (i.e., polymerized by conventional photopolymerization and/or chemical polymerization techniques) prior to adherence of the material. It is significant if the composition can be formulated to promote adhesion to both enamel and dentin. It is particularly significant if the composition can be formulated to function as the etchant, primer, and adhesive to both enamel and dentin.
• compositions of the present invention can be used to promote the adhesion of dental restoratives (e.g., composites, fillings, sealants, inlays, onlays, crowns, bridges) or orthodontic appliances (e.g., brackets (optionally precoated with orthodontic adhesives), buccal tubes, bands, cleats, buttons, lingual retainers, and bite blockers) to dental structures.
• dental restoratives e.g., composites, fillings, sealants, inlays, onlays, crowns, bridges
• orthodontic appliances e.g., brackets (optionally precoated with orthodontic adhesives), buccal tubes, bands, cleats, buttons, lingual retainers, and bite blockers
• compositions of the present invention optionally can include fillers, solvents, dental adhesives, and/or dental primers.
• fillers can be used in the compositions of the present invention.
• Certain preferred aqueous-based embodiments (i.e., including water in the composition) of the present invention are self-etching primer and self-etching adhesive compositions with enhanced hydrolytic stability, e.g., having a room-temperature shelf-life stability of at least 1 year, and preferably at least 2 years. Additionally, preferred compositions, especially self-etching adhesive compositions, do not require any pre-mixing steps prior to application to the surface of the dental structure.
• the polymerizable bisphosphonic acids are of the following formula (Formula I):
• R 1 is an organic group that includes a polymerizable group
• R 2 is H, OR, SR, N(R) 2 , or an organic group that can optionally join with R 1 to form a carbon-carbon double bond with the carbon between the two phosphorus atoms, wherein the organic group optionally includes a polymerizable group, and further wherein each R is independently hydrogen or an organic group optionally including a polymerizable group.
• R 1 and R 2 join to form a double bond, that double bond can be the polymerizable group of R 1 .
• the polymerizable group is an ethylenically unsaturated group. More preferably, the ethylenically unsaturated group is a (meth)acrylate group, a (meth)acrylamido group, or a vinyl group.
• a particularly preferred class of polymerizable bisphosphonic acids is of the following formula (Formula II):
• x 1-3 (preferably, x is 1-2, and more preferably, 1);
• R 2 is H, OH, an alkyl group, an aryl group, an alkoxy group, an aryloxy group, or -A-(N(R 4 )C(O)C(R 3 ) ⁇ CH 2 ) x ;
• each R 3 is independently H or CH 3 (i.e, an acrylamido group or a methacrylamido group, often referred to as a (meth)acrylamido group);
• each R 4 is independently H, an alkyl group, or can be joined to A forming a cyclic organic group; and
• A is a bond or a straight chain or branched organic group.
• the ethylenically unsaturated groups (x) are not bonded to the same carbon atom of A. They can be present in their acid form or their salt form. Thus, when a compound of Formulas I or II or other bisphosphonic acids of the present invention are referred to herein, they encompass both acids and salts.
• a polymerizable bisphosphonic acid compound of the present invention is present in a composition in an amount effective to etch hard tissue. Typically, this is an amount of at least about 1 percent by weight (wt-%), based on the total weight of the composition. More preferably, a polymerizable bisphosphonic acid compound of the present invention is present in an amount of at least about 5 wt-%, based on the total weight of the composition. If more than one polymerizable bisphosphonic acid compound is used, these amounts apply to the total amount of the mixture.
• the term “organic group” means a hydrocarbon group (with optional elements other than carbon and hydrogen, such as oxygen, nitrogen, sulfur, phosphorus, and silicon) that is classified as an aliphatic group, cyclic group, or combination of aliphatic and cyclic groups (e.g., alkaryl and aralkyl groups).
• the organic groups are those that do not interfere with the formation of an etchant for a hard surface.
• aliphatic group means a saturated or unsaturated linear or branched hydrocarbon group. This term is used to encompass alkyl, alkenyl, and alkynyl groups, for example.
• alkyl group means a saturated linear or branched hydrocarbon group including, for example, methyl, ethyl, isopropyl, t-butyl, heptyl, dodecyl, octadecyl, amyl, 2-ethylhexyl, and the like.
• alkenyl group means an unsaturated, linear or branched hydrocarbon group with one or more carbon-carbon double bonds, such as a vinyl group.
• alkynyl group means an unsaturated, linear or branched hydrocarbon group with one or more carbon-carbon triple bonds.
• cyclic group means a closed ring hydrocarbon group that is classified as an alicyclic group, aromatic group, or heterocyclic group.
• alicyclic group means a cyclic hydrocarbon group having properties resembling those of aliphatic groups.
• aromatic group or “aryl group” means a mono- or polynuclear aromatic hydrocarbon group.
• heterocyclic group means a closed ring hydrocarbon in which one or more of the atoms in the ring is an element other than carbon (e.g., nitrogen, oxygen, sulfur, etc.).
• substitution is anticipated on the organic groups of the polymerizable bisphosphonic acid compounds of the present invention.
• group and “moiety” are used to differentiate between chemical species that allow for substitution or that may be substituted and those that do not allow or may not be so substituted.
• group when the term “group” is used to describe a chemical substituent, the described chemical material includes the unsubstituted group and that group with O, N, Si, P, or S atoms, for example, in the chain (as in an alkoxy group) as well as carbonyl groups or other conventional substitution.
• alkyl group is intended to include not only pure open chain saturated hydrocarbon alkyl substituents, such as methyl, ethyl, propyl, t-butyl, and the like, but also alkyl substituents bearing further substituents known in the art, such as hydroxy, alkoxy, alkylsulfonyl, halogen atoms, cyano, nitro, amino, carboxyl, etc.
• alkyl group includes ether groups, haloalkyls, nitroalkyls, carboxyalkyls, hydroxyalkyls, sulfoalkyls, etc.
• alkyl moiety is limited to the inclusion of only pure open chain saturated hydrocarbon alkyl substituents, such as methyl, ethyl, propyl, t-butyl, and the like.
• the organic groups can include up to 20 carbon atoms (preferably, up to 18 carbon atoms, and more preferably up to 12 carbon atoms).
• the organic group can include a polymerizable group.
• polymerizable groups include, for example, (meth)acrylamido groups, (meth)acryloxy groups, and vinyl groups.
• the polymerizable groups are (meth)acrylamido groups.
• the alkyl and alkoxy groups have 1-18 carbon atoms (preferably, 1-8 carbon atoms, and more preferably 14 carbon atoms), and the aryl and aryloxy groups have 4-18 carbon atoms (preferably, 5-12 carbon atoms, and more preferably 6-10 carbon atoms).
• R 2 is H, OH, (C1-C4)alkyl group, or a (C 1 -C 4 )alkoxy group.
• R 2 is OH or a (C1-C4)alkoxy group.
• R 2 is H, OH, methyl, or methoxy.
• the alkyl group has 1-18 carbon atoms (preferably, 1-8 carbon atoms, and more preferably 1-4 carbon atoms).
• R 4 is H, a (C1-C4)alkyl group, or can be joined to A forming a cyclic organic group.
• R 4 is H or methyl.
• A is a straight chain alkyl group, preferably having up to 20 carbon atoms.
• n 5.
• compositions of the present invention can also include one or more polymerizable components in addition to the polymerizable bisphosphonic acid, thereby forming polymerizable compositions.
• the compositions are photopolymerizable, i.e., the compositions contain a photopolymerizable component and a photoinitiator (i.e., a photoinitiator system) that upon irradiation with actinic radiation initiates the polymerization (or hardening) of the composition.
• a photoinitiator i.e., a photoinitiator system
• Such photopolymerizable compositions can be free radically polymerizable.
• the compositions are chemically polymerizable, i.e., the compositions contain a chemically polymerizable component and a chemical initiator (i.e., initiator system) that can polymerize, cure, or otherwise harden the composition without dependence on irradiation with actinic radiation.
• a chemical initiator i.e., initiator system
• Such chemically polymerizable compositions are sometimes referred to as “self-cure” compositions and may include glass ionomer cements, resin-modified glass ionomer cements, redox cure systems, and combinations thereof.
• Suitable photopolymerizable compositions may include photopolymerizable components (e.g., compounds) that include ethylenically unsaturated compounds (which contain free radically active unsaturated groups).
• photopolymerizable components e.g., compounds
• ethylenically unsaturated compounds include acrylic acid esters, methacrylic acid esters, hydroxy-functional acrylic acid esters, hydroxy-functional methacrylic acid esters, and combinations thereof.
• Photopolymerizable compositions may include compounds having free radically active functional groups that may include monomers, oligomers, and polymers having one or more ethylenically unsaturated groups. Suitable compounds contain at least one ethylenically unsaturated bond and are capable of undergoing addition polymerization.
• Such free radically polymerizable compounds include mono-, di- or poly-(meth)acrylates (i.e., acrylates and methacrylates) such as, methyl (meth)acrylate, ethyl (meth)acrylate, isopropyl (meth)acrylate, n-hexyl (meth)acrylate, stearyl (meth)acrylate, allyl (meth)acrylate, glycerol tri(meth)acrylate, ethyleneglycol di(meth)acrylate, diethyleneglycol di(meth)acrylate, triethyleneglycol di(meth)acrylate, 1,3-propanediol di(meth)acrylate, trimethylolpropane tri(meth)acrylate, 1,2,4-butanetriol tri(meth)acrylate, 1,4-cyclohexanediol di(meth)acrylate, pentaerythritol tetra(meth)acrylate, sorb
• Suitable free radically polymerizable compounds include siloxane-functional (meth)acrylates as disclosed, for example, in WO-00/38619 (Guggenberger et al.), WO-01/92271 (Weinmann et al.), WO-01/07444 (Guggenberger et al.), WO-00/42092 (Guggenberger et al.) and fluoropolymer-functional (meth)acrylates as disclosed, for example, in U.S. Pat. No. 5,076,844 (Fock et al.), U.S. Pat. No.
• the polymerizable component may also contain hydroxyl groups and free radically active functional groups in a single molecule.
• examples of such materials include hydroxyalkyl (meth)acrylates, such as 2-hydroxyethyl (meth)acrylate and 2-hydroxypropyl (meth)acrylate; glycerol mono- or di-(meth)acrylate; trimethylolpropane mono- or di-(meth)acrylate; pentaerythritol mono-, di-, and tri-(meth)acrylate; sorbitol mono-, di-, tri-, tetra-, or penta-(meth)acrylate; and 2,2-bis[4-(2-hydroxy-3-methacryloxypropoxy)phenyl]propane (bisGMA).
• bisGMA 2,2-bis[4-(2-hydroxy-3-methacryloxypropoxy)phenyl]propane
• Suitable ethylenically unsaturated compounds are also available from a wide variety of commercial sources, such as Sigma-Aldrich, St. Louis, Mo. and Rhom and Tech, Inc., Darmstadt, Germany. Mixtures of ethylenically unsaturated compounds can be used if desired.
• the polymerizable component may also be an ethylenically unsaturated compound with acid functionality.
• ethylenically unsaturated compounds with acid functionality is meant to include monomers, oligomers, and polymers having ethylenic unsaturation and acid and/or acid-precursor functionality.
• Acid-precursor functionalities include, for example, anhydrides, acid halides, and pyrophosphates. Such ethylenically unsaturated compounds with acid functionality are present in certain embodiments of the present invention.
• Exemplary ethylenically unsaturated compounds with acid functionality include, for example, ⁇ , ⁇ -unsaturated acidic compounds such as glycerol phosphate mono(meth)acrylates, glycerol phosphate di(meth)acrylates, hydroxyethyl (meth)acrylate phosphates, citric acid mono-, di-, and tri-(meth)acrylates, poly(meth)acrylated oligomaleic acid, poly(meth)acrylated polymaleic acid, poly(meth)acrylated poly(meth)acrylic acid, poly(meth)acrylated polycarboxyl-polyphosphonic acid, poly(meth)acrylated polychlorophosphoric acid, poly(meth)acrylated polysulfonate, poly(meth)acrylated polyboric acid, and the like.
• Suitable compositions of the present invention include an ethylenically unsaturated compound with acid functionality having at least one P—OH moiety.
• Additional ethylenically unsaturated compounds with acid functionality include, for example, AA:ITA:IEM (copolymer of acrylic acid:itaconic acid with pendent methacrylate made by reacting AA:ITA copolymer with sufficient 2-isocyanatoethyl methacrylate to convert a portion of the acid groups of the copolymer to pendent methacrylate groups as described, for example, in Example 11 of U.S. Pat. No. 5,130,347 (Mitra)); and those recited in U.S. Pat. No. 4,259,075 (Yamauchi et al.), U.S. Pat. No.
• Preferred photopolymerizable components include 2-hydroxyethyl methacrylate (HEMA), PEGDMA (polyethyleneglycol dimethacrylate having a molecular weight of about 400), AA:ITA:IEM (copolymer of acrylic acid:itaconic acid with pendent methacrylate as described in the Examples Section), bisGMA, UDMA (urethane dimethacrylate), and GDMA (glycerol dimethacrylate).
• HEMA 2-hydroxyethyl methacrylate
• PEGDMA polyethyleneglycol dimethacrylate having a molecular weight of about 400
• AA:ITA:IEM copolymer of acrylic acid:itaconic acid with pendent methacrylate as described in the Examples Section
• bisGMA bisGMA
• UDMA urethane dimethacrylate
• GDMA glycerol dimethacrylate
• Suitable photoinitiators i.e., photoinitiator systems that include one or more compounds
• Suitable photoinitiators for polymerizing free radically photopolymerizable compositions include binary and tertiary systems.
• Typical binary photoinitiators include a photosensitizer and an electron donor compound.
• Typical tertiary photoinitiators include an iodonium salt, a photosensitizer, and an electron donor compound as described in U.S. Pat. No. 5,545,676 (Palazzotto et al.).
• Preferred iodonium salts are the diaryl iodonium salts, e.g., diphenyliodonium chloride, diphenyliodonium hexafluorophosphate, and diphenyliodonium tetrafluoroboarate.
• Preferred photosensitizers are monoketones and diketones that absorb some light within a range of about 450 nm to about 520 nm (preferably, about 450 nm to about 500 nm).
• Exemplary alpha-diketones include 2,3-butanedione, 2,3-pentanedione, 2,3-hexanedione, 3,4-hexanedione, 2,3-heptanedione, 3,4-heptanedione, 2,3-octanedione, 4,5-octanedione, benzil, 2,2′-, 3,3′-, and 4,4′-dihydroxybenzil, furil, di-3,3′-indolylethanedione, 2,3-bomanedione (camphorquinone), biacetyl, 1,2-cyclohexanedione, 3,3,6,6-tetramethylcyclohexanedione, 1,2-naphthaquinone, acenaphthaquinone, and the like.
• Additional diketones include 1-aryl-2-alkyl-1,2-ethanediones such as 1-phenyl-1,2-propanedione, as disclosed, for example, in U.S. Pat. No. 6,204,302 (Rawls et al.). More preferred compounds are alpha diketones that have some light absorption within a range of about 450 nm to about 520 nm (even more preferably, about 450 to about 500 nm). Preferred compounds are camphorquinone, benzil, furil, 3,3,6,6-tetramethylcyclohexanedione, phenanthraquinone and other cyclic alpha diketones. Most preferred is camphorquinone.
• Preferred electron donor compounds include substituted amines, e.g., ethyl dimethylaminobenzoate.
• Suitable photoinitiators for polymerizing free radically photopolymerizable compositions include the class of phosphine oxides that typically have a functional wavelength range of about 380 nm to about 1200 nm.
• Preferred phosphine oxide free radical initiators with a functional wavelength range of about 380 nm to about 450 nm are acyl and bisacyl phosphine oxides such as those described in U.S. Pat. No. 4,298,738 (Lechtken et al.), U.S. Pat. No. 4,324,744 (Lechtken et al.), U.S. Pat. No. 4,385,109 (Lechtken et al.), U.S. Pat. No.
• phosphine oxide photoinitiators capable of free-radical initiation when irradiated at wavelength ranges of greater than about 380 nm to about 450 nm include bis(2,4,6-trimethylbenzoyl)phenyl phosphine oxide (IRGACURE 819, Ciba Specialty Chemicals, Tarrytown, N.Y.), bis(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl) phosphine oxide (CGI 403, Ciba Specialty Chemicals), a 25:75 mixture, by weight, of bis(2,6-dimethoxybenzoyl)-2,4,4-trimethylpentyl phosphine oxide and 2-hydroxy-2-methyl-1-phenylpropan-1-one (IRGACURE 1700, Ciba Specialty Chemicals), a 1:1 mixture, by weight, of bis(2,4,6-trimethylbenzoyl)phenyl phosphine oxide and
• the phosphine oxide initiator is present in the photopolymerizable composition in catalytically effective amounts, such as from about 0.1 weight percent to about 5.0 weight percent, based on the total weight of the composition.
• Tertiary amine reducing agents may be used in combination with an acylphosphine oxide.
• Illustrative tertiary amines useful in the invention include ethyl 4-(N,N-dimethylamino)benzoate and N,N-dimethylaminoethyl methacrylate.
• the amine reducing agent is present in the photopolymerizable composition in an amount from about 0.1 weight percent to about 5.0 weight percent, based on the total weight of the composition.
• the chemically polymerizable compositions may include glass ionomer cements such as conventional glass ionomers that typically employ as their main ingredients a homopolymer or copolymer of an ethylenically unsaturated carboxylic acid (e.g., poly(acrylic acid), copoly(acrylic, itaconic acid), copoly(acrylic, maleic acid), and the like), a fluoroaluminosilicate (“FAS”) glass, water, and a chelating agent such as tartaric acid.
• Conventional glass ionomers i.e., glass ionomer cements
• Conventional glass ionomers typically are supplied in powder/liquid formulations that are mixed just before use. The mixture will undergo self-hardening in the dark due to an ionic reaction between the acidic repeating units of the polycarboxylic acid and cations leached from the glass.
• the glass ionomer cements may include resin-modified glass ionomer (“RMGI”) cements. Like a conventional glass ionomer, an RMGI cement employs an FAS glass. However, the organic portion of an RMGI is different.
• the polycarboxylic acid is modified to replace or end-cap some of the acidic repeating units with pendent curable groups and a photoinitiator is added to provide a second cure mechanism, e.g., as described in U.S. Pat. No. 5,130,347 (Mitra). Acrylate or methacrylate groups are usually employed as the pendant curable group.
• the cement in another type of RMGI, includes a polycarboxylic acid, an acrylate or methacrylate-functional monomer and a photoinitiator, e.g., as in Mathis et al., “Properties of a New Glass lonomer/Composite Resin Hybrid Restorative,” Abstract No. 51, J. Dent Res., 66:113 (1987) and as in U.S. Pat. No. 5,063,257 (Akahane et al.), U.S. Pat. No. 5,520,725 (Kato et al.), U.S. Pat. No. 5,859,089 (Qian), U.S. Pat. No.
• the cement may include a polycarboxylic acid, an acrylate or methacrylate-functional monomer, and a redox or other chemical cure system, e.g., as described in U.S. Pat. No. 5,154,762 (Mitra et al.), U.S. Pat. No. 5,520,725 (Kato et al.), and U.S. Pat. No. 5,871,360 (Kato).
• the cement may include various monomer-containing or resin-containing components as described in U.S. Pat. No.
• RMGI cements are preferably formulated as powder/liquid or paste/paste systems, and contain water as mixed and applied. The compositions are able to harden in the dark due to the ionic reaction between the acidic repeating units of the polycarboxylic acid and cations leached from the glass, and commercial RMGI products typically also cure on exposure of the cement to light from a dental curing lamp. RMGI cements that contain a redox cure system and that can be cured in the dark without the use of actinic radiation are described in U.S. Patent Publication No. 2003/0087986 (Filed Jul. 27, 2001).
• the chemically polymerizable compositions may include redox cure systems that include a polymerizable component (e.g., an ethylenically unsaturated polymerizable component) and redox agents that include an oxidizing agent and a reducing agent.
• a polymerizable component e.g., an ethylenically unsaturated polymerizable component
• redox agents that include an oxidizing agent and a reducing agent.
• Suitable polymerizable components, redox agents, optional acid-functional components, and optional fillers that are useful in the present invention are described in U.S. Patent Publication No. 2003/0166740 (Filed Apr. 12, 2002) and U.S. Patent Publication No. 2003/0195273 (Filed Apr. 12, 2002).
• the reducing and oxidizing agents should react with or otherwise cooperate with one another to produce free-radicals capable of initiating polymerization of the resin system (e.g., the ethylenically unsaturated component).
• This type of cure is a dark reaction, that is, it is not dependent on the presence of light and can proceed in the absence of light.
• the reducing and oxidizing agents are preferably sufficiently shelf-stable and free of undesirable colorization to permit their storage and use under typical dental conditions. They should be sufficiently miscible with the resin system (and preferably water-soluble) to permit ready dissolution in (and discourage separation from) the other components of the polymerizable composition.
• Useful reducing agents include ascorbic acid, ascorbic acid derivatives, and metal complexed ascorbic acid compounds as described in U.S. Pat. No. 5,501,727 (Wang et al.); amines, especially tertiary amines, such as 4-tert-butyl dimethylaniline; aromatic sulfinic salts, such as p-toluenesulfinic salts and benzenesulfinic salts; thioureas, such as 1-ethyl-2-thiourea, tetraethyl thiourea, tetramethyl thiourea, 1,1-dibutyl thiourea, and 1,3-dibutyl thiourea; and mixtures thereof.
• secondary reducing agents may include cobalt (II) chloride, ferrous chloride, ferrous sulfate, hydrazine, hydroxylamine (depending on the choice of oxidizing agent), salts of a dithionite or sulfite anion, and mixtures thereof.
• the reducing agent is an amine.
• Suitable oxidizing agents will also be familiar to those skilled in the art, and include but are not limited to persulfuric acid and salts thereof, such as sodium, potassium, ammonium, cesium, and alkyl ammonium salts.
• Additional oxidizing agents include peroxides such as benzoyl peroxides, hydroperoxides such as cumyl hydroperoxide, t-butyl hydroperoxide, and amyl hydroperoxide, as well as salts of transition metals such as cobalt (III) chloride and ferric chloride, cerium (IV) sulfate, perboric acid and salts thereof, permanganic acid and salts thereof, perphosphoric acid and salts thereof, and mixtures thereof.
• oxidizing agent it may be desirable to use more than one oxidizing agent or more than one reducing agent. Small quantities of transition metal compounds may also be added to accelerate the rate of redox cure. In some embodiments it may be preferred to include a secondary ionic salt to enhance the stability of the polymerizable composition as described in U.S. Patent Publication No. 2003/0195273 (Filed Apr. 12, 2002).
• the reducing and oxidizing agents are present in amounts sufficient to permit an adequate free-radical reaction rate. This can be evaluated by combining all of the ingredients of the polymerizable composition except for the optional filler, and observing whether or not a hardened mass is obtained.
• a reducing agent is present in an amount of at least about 0.01 wt-%, and more preferably at least about 0.1 wt-%, based on the total weight (including water) of the components of the polymerizable composition.
• a reducing agent is present in an amount of no greater than about 10 wt-%, and more preferably no greater than about 5 wt-%, based on the total weight (including water) of the components of the polymerizable composition.
• an oxidizing agent is present in an amount of at least about 0.01 wt-%, and more preferably at least about 0.10 wt-%, based on the total weight (including water) of the components of the polymerizable composition.
• an oxidizing agent is present in an amount of no greater than about 10 wt-%, and more preferably no greater than about 5 wt-%, based on the total weight (including water) of the components of the polymerizable composition.
• the reducing or oxidizing agents can be microencapsulated as described in U.S. Pat. No. 5,154,762 (Mitra et al.). This will generally enhance shelf stability of the polymerizable composition, and if necessary permit packaging the reducing and oxidizing agents together.
• the oxidizing and reducing agents can be combined with an acid-functional component and optional filler and kept in a storage-stable state.
• the reducing and oxidizing agents can be combined with an FAS glass and water and maintained in a storage-stable state.
• a redox cure system can be combined with other cure systems, e.g., with a glass ionomer cement and with a photopolymerizable composition such as described U.S. Pat. No. 5,154,762 (Mitra et al.).
• the polymerizable compositions that utilize a redox cure system can be supplied in a variety of forms including two-part powder/liquid, paste/liquid, and paste/paste systems. Other forms employing multi-part combinations (i.e., combinations of two or more parts), each of which is in the form of a powder, liquid, gel, or paste are also possible.
• one part typically contains the reducing agent(s) and another part typically contains the oxidizing agent(s). Therefore, if the reducing agent is present in one part of the system, then the oxidizing agent is typically present in another part of the system.
• the reducing agent and oxidizing agent can be combined in the same part of the system through the use of the microencapsulation technique.
• compositions of the present invention can also contain fillers.
• Fillers may be selected from one or more of a wide variety of materials suitable for incorporation in compositions used for dental applications, such as fillers currently used in dental restorative compositions, and the like.
• the filler is preferably finely divided.
• the filler can have a unimodial or polymodial (e.g., bimodal) particle size distribution.
• the maximum particle size (the largest dimension of a particle, typically, the diameter) of the filler is less than about 10 micrometers, and more preferably less than about 2.0 micrometers.
• the average particle size of the filler is less than about 3.0 micrometers, and more preferably less than about 0.6 micrometer.
• the filler can be an inorganic material. It can also be a crosslinked organic material that is insoluble in the resin system, and is optionally filled with inorganic filler.
• the filler should in any event be nontoxic and suitable for use in the mouth.
• the filler can be radiopaque or radiolucent.
• the filler typically is substantially insoluble in water.
• suitable inorganic fillers are naturally occurring or synthetic materials including, but not limited to: quartz; nitrides (e.g., silicon nitride); glasses derived from, for example, Ce, Sb, Sn, Ba, Zn, and Al; feldspar; borosilicate glass; kaolin; talc; titania; low Mohs hardness fillers such as those described in U.S. Pat. No.
• submicron silica particles e.g., pyrogenic silicas such as those available under the trade designations AEROSIL, including “OX 50,” “130,” “150” and “200” silicas from Degussa Corp., Akron, Ohio and CAB-O-SIL M5 silica from Cabot Corp., Tuscola, Ill.
• suitable organic filler particles include filled or unfilled pulverized polycarbonates, polyepoxides, and the like.
• Preferred non-acid-reactive filler particles are quartz, submicron silica, and non-vitreous microparticles of the type described in U.S. Pat. No. 4,503,169 (Randklev). Mixtures of these non-acid-reactive fillers are also contemplated, as well as combination fillers made from organic and inorganic materials.
• the surface of the filler particles can also be treated with a coupling agent in order to enhance the bond between the filler and the resin.
• suitable coupling agents include gamma-methacryloxypropyltrimethoxysilane, gamma-mercaptopropyltriethoxysilane, gamma-aminopropyltrimethoxysilane, and the like.
• the filler can also be an acid-reactive filler.
• An acid-reactive filler is typically used in combination with an acid-functional resin component, and may or may not be used in combination with a nonreactive filler.
• the acid-reactive filler can, if desired, also possess the property of releasing fluoride.
• Suitable acid-reactive fillers include metal oxides, glasses, and metal salts.
• Preferred metal oxides include barium oxide, calcium oxide, magnesium oxide, and zinc oxide.
• Preferred glasses include borate glasses, phosphate glasses, and fluoroaluminosilicate (“FAS”) glasses. FAS glasses are particularly preferred.
• the FAS glass preferably contains sufficient elutable cations so that a hardened dental composition will form when the glass is mixed with the components of the hardenable composition.
• the glass also preferably contains sufficient elutable fluoride ions so that the hardened composition will have cariostatic properties.
• the glass can be made from a melt containing fluoride, alumina, and other glass-forming ingredients using techniques familiar to those skilled in the FAS glassmaking art.
• the FAS glass preferably is in the form of particles that are sufficiently finely divided so that they can conveniently be mixed with the other cement components and will perform well when the resulting mixture is used in the mouth.
• the average particle size (typically, diameter) for the FAS glass is no greater than about 10 micrometers, and more preferably no greater than about 5 micrometers as measured using, for example, a sedimentation analyzer.
• Suitable FAS glasses will be familiar to those skilled in the art, and are available from a wide variety of commercial sources, and many are found in currently available glass ionomer cements such as those commercially available under the trade designations VITREMER, VITREBOND, RELY X LUTING CEMENT and KETAC-FIL (3M ESPE Dental Products, St.
• the FAS glass can optionally be subjected to a surface treatment.
• Suitable surface treatments include, but are not limited to, acid washing (e.g., treatment with a phosphoric acid), treatment with a phosphate, treatment with a chelating agent such as tartaric acid, and treatment with a silane or an acidic or basic silanol solution.
• acid washing e.g., treatment with a phosphoric acid
• a phosphate e.g., treatment with a phosphate
• a chelating agent such as tartaric acid
• mixtures of acid-reactive and non-acid-reactive fillers can be used either in the same part or in different parts.
• U.S. Pat. No. 6,306,926 discloses a number of radiopacifying fillers that can be used in both free radically polymerizable compositions, cationically polymerizable compositions, and hybrid compositions featuring both free radically and cationically polymerizable components. They are particularly advantageous for use in cationically polymerizable compositions.
• One such filler is a melt-derived filler that includes 5-25% by weight aluminum oxide, 10-35% by weight boron oxide, 15-50% by weight lanthanum oxide, and 20-50% by weight silicon oxide.
• Another filler is a melt-derived filler that includes 10-30% by weight aluminum oxide, 10-40% by weight boron oxide, 20-50% by weight silicon oxide, and 15-40% by weight tantalum oxide.
• a third filler is a melt-derived filler that includes 5-30% by weight aluminum oxide, 5-40% by weight boron oxide, 0-15% by weight lanthanum oxide, 25-55% by weight silicon oxide, and 1040% by weight zinc oxide.
• a fourth filler is a melt-derived filler that includes 15-30% by weight aluminum oxide, 15-30% by weight boron oxide, 20-50% by weight silicon oxide, and 15-40% by weight ytterbium oxide.
• a fifth filler is in the form of non-vitreous microparticles prepared by a sol-gel method in which an aqueous or organic dispersion or sol of amorphous silicon oxide is mixed with an aqueous or organic dispersion, sol, or solution of a radiopacifying metal oxide, or precursor organic or compound.
• a sixth filler is in the form of non-vitreous microparticles prepared by a sol-gel method in which an aqueous or organic dispersion or sol of amorphous silicon oxide is mixed with an aqueous or organic dispersion, sol, or solution of a radiopacifying metal oxide, or precursor organic or inorganic compound.
• compositions of the present invention preferably have an initial color remarkably different than dental structures. Color is preferably imparted to a composition through the use of a photobleachable dye.
• a composition of the present invention preferably includes at least 0.001% by weight photobleachable dye, and more preferably at least 0.002% by weight photobleachable dye, based on the total weight of the composition.
• a composition of the present invention preferably includes at most 1% by weight photobleachable dye, and more preferably at most 0.1% by weight photobleachable dye, based on the total weight of the composition. The amount of photobleachable dye may vary depending on its extinction coefficient, the ability of the human eye to discern the initial color, and the desired color change.
• the color formation and bleaching characteristics of the photobleachable dye varies depending on a variety of factors including, for example, acid strength, dielectric constant, polarity, amount of oxygen, and moisture content in the atmosphere.
• the bleaching properties of the dye can be readily determined by irradiating the composition and evaluating the change in color.
• at least one photobleachable dye is at least partially soluble in a hardenable resin.
• Exemplary classes of photobleachable dyes are disclosed, for example, in U.S. Pat. No. 6,331,080 (Cole et al.), U.S. Pat. No. 6,444,725 (Trom et al.), and U.S. Pat. No. 6,528,555 (Nikutowski et al.).
• Preferred dyes include, for example, Rose Bengal, Methylene Violet, Methylene Blue, Fluorescein, Eosin Yellow, Eosin Y, Ethyl Eosin, Eosin bluish, Eosin B, Erythrosin B, Erythrosin Yellowish Blend, Toluidine Blue, 4′,5′-Dibromofluorescein, and combinations thereof.
• the color change in the inventive compositions is initiated by light.
• the composition's color change is initiated using actinic radiation using, for example, a dental curing light which emits visible or near infrared (1R) light for a sufficient amount of time.
• the mechanism that initiates the color change in the compositions of the invention may be separate from or substantially simultaneous with the hardening mechanism that hardens the resin.
• a composition may harden when polymerization is initiated chemically (e.g., redox initiation) or thermally, and the color change from an initial color to a final color may occur subsequent to the hardening process upon exposure to actinic radiation.
• the change in composition color from an initial color to a final color is preferably quantified by a Color Test as described below. Using the Color Test, a value of ⁇ E* is determined, which indicates the total color change in a 3-dimensional color space. The human eye can detect a color change of approximately 3 ⁇ E* units in normal lighting conditions.
• the dental compositions of the present invention are preferably capable of having a color change, ⁇ E*, of at least 20; more preferably, ⁇ E* is at least 30; most preferably ⁇ E* is at least 40.
• the polymerizable compositions also may contain solvents or diluents (e.g., water, alcohols (e.g., propanol, ethanol), ketones (e.g., acetone, methyl ethyl ketone), and other nonaqueous solvents (e.g., dimethylformamide, dimethylacetamide, dimethylsulfoxide, 1-methyl-2-pyrrolidinone)).
• solvents or diluents e.g., water, alcohols (e.g., propanol, ethanol), ketones (e.g., acetone, methyl ethyl ketone), and other nonaqueous solvents (e.g., dimethylformamide, dimethylacetamide, dimethylsulfoxide, 1-methyl-2-pyrrolidinone)
• solvents or diluents e.g., water, alcohols (e.g., propanol, ethanol), ketones (e.g., ace
• Suitable fluoride releasing agents include fluoride salts as disclosed, for example, in U.S. Pat. No. 5,607,663 (Rozzi et al.), U.S. Pat. No. 5,662,887 (Rozzi et al.), U.S. Pat. No. 5,866,630 (Mitra et al.), U.S. Pat. No. 5,876,208 (Mitra et al.), U.S. Pat. No. 5,888,491 (Mitra et al.), and U.S. Pat. No. 6,312,668 (Mitra et al.).
• a preferred fluoride releasing agent includes tetrafluoroborate anions as disclosed, for example, in U.S. Pat. No. 4,871,786 (Aasen et al.).
• a preferred repeating unit of a fluoride releasing agent includes trimethylammoniumethyl methacrylate.
• hard tissue dental primers are known, which can be used as a component of compositions of the present invention or as a separate primer used in conjunction with compositions of the present invention.
• Examples of commercially available dental primers include SCOTCHBOND MULTI-PURPOSE Primer available from 3M ESPE Dental, St. Paul, Minn. and CLEARFIL SE (self-etching primer) available from Kuraray Company, Japan.
• hard tissue adhesives are known, which can be used as a component of compositions of the present invention or as a separate adhesive used in conjunction with compositions of the present invention.
• U.S. Pat. No. 4,719,149 (Aasen et al.) and references therein include a variety of materials and methods for adhering methacrylate-based composites to hard tissues.
• U.S. Pat. No. 5,256,447 (Oxman et al.) and U.S. Pat. No. 5,525,648 (Aasen et al.).
• U.S. Pat. No. 5,980,253 describes materials and methods for bonding cationically curable compositions to hard tissues.
• Such known materials and methods can be used in the processes of the present invention.
• these materials have been used in processes that initially harden the adhesive and then the restorative material. That is, conventional methods utilize one or more of the following steps: surface treatment of the tooth (e.g., etching, priming), application of a hardenable adhesive to the primed tooth surface, curing of the adhesive, placement of a restorative material on the hardened adhesive, and curing of the restorative material.
• surface treatment of the tooth e.g., etching, priming
• a hardenable adhesive to the primed tooth surface
• curing of the adhesive placement of a restorative material on the hardened adhesive
• curing of the restorative material examples include SCOTCHBOND MULTI-PURPOSE adhesive, SINGLEBOND adhesive (self-priming adhesive), and ADPER PROMPT L-POP (self-etching adhesive) all available from 3M ESPE Dental, St. Paul, Minn.
• a composition of the present invention is applied to a hard surface, typically a dental structure requiring restoration, for a time sufficient to etch, and preferably etch and prime, the surface, using conventional techniques. Thereafter, optionally, the applied composition may be rinsed, dried, or both. More preferably, a composition of the present invention is a self-etching adhesive that requires only a single application. Specific techniques are described in greater detail in the Examples Section.
• Certain methods of the present invention involve adhering an orthodontic appliance (e.g., a bracket, a buccal tube, a band, a cleat, a button, a lingual retainer, and a bite blocker) to the tooth surface after the tooth surface has been etched by a composition including a polymerizable bisphosphonic acid.
• an orthodontic adhesive can be adhered to the tooth surface, which can optionally be pre-applied to the orthodontic appliance before adhering to the tooth surface.
• the composition further includes at least one polymerizable component different from the polymerizable bisphosphonic acid
• steps of etching and priming are done simultaneously with the composition functioning as a self-etching primer composition.
• steps of etching and applying a dental adhesive are done simultaneously with the composition acting as a self-etching adhesive composition.
• the methods of the present invention can include adhering an orthodontic adhesive to the tooth surface, wherein preferably the orthodontic adhesive has been pre-applied to the orthodontic appliance before adhering to the tooth surface.
• an adhesive is subsequently applied to the primed hard surface.
• the adhesive contains an initiator and either immediately before or immediately after application of the adhesive, curing is initiated to form a polymeric structure on the hard surface.
• compositions can be used in kit form with various containers.
• an etchant composition can be packaged along with separate containers of dental primers and dental adhesives or along with a separate container of a self-priming adhesive.
• a self-etching primer composition can be packaged along with a separate container of adhesive.
• a self-etching adhesive composition could be packaged as a two-part system requiring mixing immediately prior to application and/or could be packaged along with a suitable applicator.
• Teeth Treatment A test sample was applied with a dental applicator brush over the entire surface of the prepared enamel or dentin surface and allowed to stand on the tooth surface for about 20 seconds. The coating was then thinned using a gentle to moderate stream of air for about 1-2 seconds. Using a clean application brush, an overcoat adhesive layer was optionally applied on top of the sample layer. The adhesive materials utilized are shown in Table 1. The overcoat adhesive layer was air thinned with a gentle stream of air for about 1-2 seconds and then light cured for 10 seconds. A 2.5-mm thick Teflon mold with a hole approximately 4.7 mm in diameter was clamped to the embedded tooth such that the hole in the mold exposed part of the adhesively prepared tooth surface.
• a composite material FILTEK Z250 Universal Restorative (3M Company, St. Paul, Minn.), was filled into the hole such that the hole was completely filled, but not overfilled, and light cured per manufacturer's instructions to form a “button” that was adhesively attached to the tooth.
• IEM 2-Isocyanoethyl methacrylate Sigma-Aldrich, St. Louis, MO
• AA:ITA:IEM Polymer made by reacting AA:ITA copolymer with sifficient IEM to convert 16 mole percent of the acid groups of the copolymer to pendent methacrylate groups, according to the dry polymer preparation of Example 11 of U.S. Pat. No. 5,130,347.
• HEMA 2-Hydroxyethyl methacrylate (Sigma-Aldrich) CPQ Camphorquinone (Sigma-Aldrich) EDMAB Ethyl 4-(N,N-dimethylamino)benzoate (Sigma-Aldrich) DPIHFP Diphenyliodonium Hexafluorophosphate (Alfa Aesar, Ward Hill, MA) PEGDMA 400 Polyethyleneglycol dimethacrylate (Sartomer, Exton, PA)
• a 250-ml 3-neck flask was equipped with a mechanical stirrer, dry ice/acetone condenser connected to a caustic scrubber, and a thermocouple. The system was flushed with nitrogen for 20 minutes. Added with continuous stirring at room temperature were 6-aminocaproic acid (52.5 g, 0.40 mol; Sigma-Aldrich), phosphorous acid (32 g, 0.38 mol), and methanesulfonic acid (160 ml). The mixture was heated to 65° C. and then phosphorus trichloride (PCl 3 , 70 ml, 0.80 mol) was added over 20 minutes using a dropping funnel. Stirring was continued at 65° C. overnight.
• 6-aminocaproic acid 52.5 g, 0.40 mol; Sigma-Aldrich
• phosphorous acid 32 g, 0.38 mol
• methanesulfonic acid 160 ml
• the clear reaction mixture was cooled to 30° C. and then quenched into 400 ml of ice-cold water. An additional 200 ml of water was used to rinse the reaction flask and then added to the cold mixture. The aqueous mixture was warmed to room temperature and then heated to reflux for 5 hours. The mixture was cooled to 20° C. and the pH was raised to 4.3 using 50 wt.-% aqueous sodium hydroxide. The clear mixture was cooled in an ice bath for 2 hours during which time a white crystalline solid formed. The solid was isolated by vacuum filtration. The filter cake was washed with ice-cold water (2 50-ml portions) and then ethanol (100 ml).
• the white solid was dried by air for 2 days and then with a vacuum pump overnight to give a white solid in 93% yield.
• the solid was characterized as (6-amino-1-hydroxyhexylidene)bisphosphonic acid monosodium salt (Compound A) having the following Nuclear Magnetic Resonance (NMR) values: 1 H NMR (D 2 O) ⁇ 2.90 (t, 2H), 1.84-1.94 (m, 2H), 1.62-1.70 (m, 2H), 1.53-1.61 (m, 2H), 1.32-1.40 (m, 2H); 13 C NMR ⁇ 74.5 (t), 39.5, 33.5, 26.5 (s+s), 23; 31 P NMR ⁇ 19.5.
• NMR Nuclear Magnetic Resonance
• Compound B was prepared from 4-aminobutyric acid (Sigma-Aldrich) by the same procedure as described for Compound A. A white solid was isolated in 90.8% yield and was characterized as (4-amino-1-hydroxybutylidene)bisphosphonic acid monosodium salt (Compound B) having the following NMR values: 1 H NMR (D 2 O) ⁇ 3.0 (m, 2H), 2.0 (m, 4H); 13 C NMR ⁇ 74.5 (t), 41, 32, 24; 31 P NMR ⁇ 19.0 (s).
• a 250-ml flask was fitted with a mechanical stirrer, a thermocouple, an addition funnel, and a reflux condenser with dry ice which was connected to a caustic scrubber.
• the system was flushed with nitrogen and charged with 12-aminododecanoic acid (21.04 g, 0.098 mol; Advanced Synthesis Technologies, San Ysidro, Calif.), phosphorous acid (8.00 g, 0.098 mol), and methanesulfonic acid (40 ml).
• the mixture was heated to 65° C., PCl 3 (26.83 g, 0.195 mol) was added over 20 min, and the mixture was maintained at 65° C. overnight.
• the mixture was cooled to 60° C.
• the solid was characterized as (12-amino-1-hydroxydodecylidene)bisphosphonic acid (Compound C) having the following NMR values (recorded using a KOH solution of the solid): 1 H NMR (D 2 O) ⁇ 2.45 (t, 2H), 1.65-1.80 (m, 2H), 1.35-1.45 (m, 2H), 1.25-1.30 (m, 2H), 1.05-1.20 (m, 14H); 13 C NMR ⁇ 77.1 (t), 40.9, 36.7, 32, 30.8, 29.4 (s+s), 29.0, 28.8 (s+s), 26, 24; 31 P NMR ⁇ 19.5 (s).
• Compound D was prepared from 11-aminoundecanoic acid (Sigma-Aldrich) by the same procedure as described for Compound C. A white solid was isolated in 92.96% yield and was determined to have 1 H, 13C, and 31 P NMR values (recorded using a KOH solution of the solid) consistent with the compound (11-amino-1-hydroxyundecylidene)bisphosphonic acid (Compound D).
• the solid was characterized as (1-hydroxy-6-methacrylamidohexylidene)bisphosphonic acid (Example 1) having the following NMR values: 1 H NMR (D20) ⁇ 5.65 (s, 1H), 5.35 (s, 1H), 3.2 (t, 2H), 1.95-2.05 (m, 2H), 1.9 (s, 3H), 1.65-1.75 (m, 2H), 1.5-1.6 (m, 2H), 1.25-1.35 (m, 2H); 13 C NMR ⁇ 171, 141, 121, 74 (t), 41, 35, 31, 29, 24, 19; 31 P NMR (single peak, not referenced).
• Example 1 The hydrolytic stability of Example 1 was demonstrated by aging in water for 5 months at 45° C. without any detectable hydrolysis (based on 31 P NMR) being observed.
• Example 1A (1-Hydroxy-6-acrylamidohexylidene)bisphosphonic acid (white solid, Example 1A) was prepared and characterized as described for Example 1, except that acryloyl chloride was substituted for methacryloyl chloride.
• Example 2 was prepared from Compound B by the same procedure as described for Example 1. A white solid was isolated in 74.8% yield and was characterized as (1-hydroxy-4-methacrylamidobutylidene)bisphosphonic acid (Example 2) having the following NMR values: 1 H NMR (D 2 O) ⁇ 5.55 (s, 1H), 5.30 (s, 1H), 3.15 (t, 2H), 1.85-2.00 (m, 2H), 1.80 (s, 3H), 1.70-1.80 (m, 2H);
• Example 4 was prepared from Compound D by the same procedure as described for Example 3. A white solid was isolated in 78.95% yield and was determined to have 1 H, 13 C, and 31 P NMR values (recorded using a KOH solution of the solid) consistent with the compound (1-hydroxy-11-methacrylamidoundecylidene)bisphosphonic acid (Example 4).
• Tetraalkyl methanebisphosphonates react with aliphatic and aromatic aldehydes to produce tetraalkyl alkylidene and arylidene methanebisphosphonates (Formula I where R 1 and R 2 form a double bond with the central carbon of the P—C—P group and with alkyl groups on the 4 P—OH groups).
• the resulting tetraalkyl alkylidene and arylidene methanebisphosphonates can be hydrolyzed in acid to yield the corresponding alkylidene and arylidene methanebisphosphonic acids.
• R 1 and R 2 are CH 2 ⁇ C(CH 3 )C(O)NH(CH 2 ) 3 CH ⁇ )
• Tetraalkyl methanebisphosphonates react with aliphatic and aromatic halides (e.g., chlorides, bromides, and iodides) to produce tetraalkyl alkyl- and aryl-methanebisphosphonates (Formula I where R 1 is alkyl or aryl, R 2 is H, and with alkyl groups on the 4 P—OH groups).
• aliphatic and aromatic halides e.g., chlorides, bromides, and iodides
• methyl 6-chlorohexanoate is reacted with tetramethyl methanebisphosphonate to produce tetramethyl 5-methoxycarbonylpentyl-methanebisphosphonate that is then hydrolyzed to yield 5-carboxypentyl-methanebisphosphonic acid, and then hydrogenated to reduce the carboxy group to a hydroxymethylene group.
• the resulting 6-hydroxyhexyl-methanebisphosphonic acid is then methacrylated with methacryloyl chloride to afford 6-methacryloxyhexyl-methanebisphosphonic acid.
• R2 is NHCOCCH 3 ⁇ CH 2 , R 3 is CH 3 , R 4 is H, and A is —CH(CH 3 )CH 2 —)
• the starting material 1,3-diamino-butane-1,1-bisphosphonic acid can be prepared by the reaction of 3-aminobutyronitrile with phosphorus-tribromide in dioxane followed by hydrolysis and crystallization according to the following procedure.
• 3-Aminobutyronitrile (21 g, 0.25 mol) is dissolved in 100 ml dioxane and is reacted with phosphorus-tribromide (135.5 g, 0.5 mol) at 30° C. for 24 hours. Water is added (27 g, 1.5 mol) and the mixture is heated to 65° C. for 3 hours.
• Example 9 (1,3-bis(methacrylamido)butane-1,1-bisphosphonic Acid) can be prepared by the reaction of 1,3-diaminobutane-1,1-bisphosphonic acid with methacryloyl chloride according to the following procedure. Sodium hydroxide pellets (28.0 g, 0.70 mol) are dissolved in water (90 ml) in a 250-ml 2-neck flask equipped with a mechanical stirrer. The resulting solution is cooled in an ice bath for 15 minutes. With vigorous stirring, 1,3-diaminobutane-1,1-bisphosphonic acid (24.81 g, 0.100 mol) is added and the resulting mixture is stirred for one hour.
• 1,3-diaminobutane-1,1-bisphosphonic acid 24.81 g, 0.100 mol
• compositions of the present invention were prepared by the following general procedure.
• a solid bisphosphonic acid derivative e.g., Example 1 or 1A
• water optionally a polymerizable component
• optionally other ingredients such as, additional polymerizable components, surfactants, salts, and initiators.
• the vial was tightly capped and vigorously shaken by hand for about 30 seconds. Based on visual observations, the resulting compositions were clear, homogeneous solutions. Following mixing, the compositions were transferred into an opaque vial for evaluation according to the Shear Bond Strength Test Method described herein.
• compositions prepared in this manner are listed in Table 1 along with the optional adhesives utilized in the Test Method and the results obtained for shear bond strength to enamel and dentin. Negative controls were run for comparison and included SINGLEBOND Adhesive only (Control 1) and SCOTCHBOND Multipurpose Plus Adhesive only (Control 2). The results of these two Controls showed relatively low adhesion for adhesives applied to an enamel or dentin surface that had not been treated with an etchant-containing material.
• Example 12 is noted as an example of a self-etching adhesive composition, in that it was used as both an etchant and an adhesive to treat the tooth surface before curing and adherence of the composite material.
• Selected bisphosphonic acid derivatives of the present invention could be shown by Scanning Electron Microscopy (SEM) to etch the enamel surface of a tooth.
• SEM Scanning Electron Microscopy
• the self-etching primer composition Example 11 was applied to an enamel tooth surface prepared using 320-grit sandpaper. The composition was allowed to remain for 20 seconds and then rinsed off the surface with distilled water. The tooth surface was dried and scanned using standard SEM techniques. The SEM image showed an etched pattern on the treated enamel.

Landscapes

• Health & Medical Sciences (AREA)
• Oral & Maxillofacial Surgery (AREA)
• Epidemiology (AREA)
• Life Sciences & Earth Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Plastic & Reconstructive Surgery (AREA)
• Dental Preparations (AREA)

Priority Applications (7)

Applications Claiming Priority (2)

Related Child Applications (1)

Publications (1)

Family

ID=32717879

Family Applications (2)

Family Applications After (1)

Country Status (5)

Cited By (44)

Families Citing this family (29)

Citations (92)

Family Cites Families (110)

• 2003
  • 2003-12-05 US US10/729,497 patent/US20040206932A1/en not_active Abandoned
  • 2003-12-29 WO PCT/US2003/041487 patent/WO2004060327A1/en active Application Filing
  • 2003-12-29 EP EP03808595A patent/EP1578377A1/en not_active Withdrawn
  • 2003-12-29 EP EP11185227A patent/EP2407142A1/en not_active Withdrawn
  • 2003-12-29 AU AU2003303644A patent/AU2003303644A1/en not_active Abandoned
  • 2003-12-29 JP JP2005508629A patent/JP4638349B2/ja not_active Expired - Fee Related
• 2008
  • 2008-11-21 US US12/275,954 patent/US8404144B2/en not_active Expired - Fee Related

Patent Citations (98)

Also Published As

Similar Documents

Legal Events